Cargando…

Drug repurposing strategies for COVID-19

COVID-19 has now been declared a pandemic and new treatments are urgently needed as we enter a phase beyond containment. Developing new drugs from scratch is a lengthy process, thus impractical to face the immediate global challenge. Drug repurposing is an emerging strategy where existing medicines,...

Descripción completa

Detalles Bibliográficos
Autor principal: Senanayake, Suranga L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Newlands Press Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117595/
http://dx.doi.org/10.4155/fdd-2020-0010
_version_ 1783514403430203392
author Senanayake, Suranga L
author_facet Senanayake, Suranga L
author_sort Senanayake, Suranga L
collection PubMed
description COVID-19 has now been declared a pandemic and new treatments are urgently needed as we enter a phase beyond containment. Developing new drugs from scratch is a lengthy process, thus impractical to face the immediate global challenge. Drug repurposing is an emerging strategy where existing medicines, having already been tested safe in humans, are redeployed to combat difficult-to-treat diseases. While using such repurposed drugs individually may ultimately not yield a significant clinical benefit, carefully combined cocktails could be very effective, as was for HIV in the 1990s; the urgent question now being which combination.
format Online
Article
Text
id pubmed-7117595
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Newlands Press Ltd
record_format MEDLINE/PubMed
spelling pubmed-71175952020-04-02 Drug repurposing strategies for COVID-19 Senanayake, Suranga L Future Drug Discov Editorial COVID-19 has now been declared a pandemic and new treatments are urgently needed as we enter a phase beyond containment. Developing new drugs from scratch is a lengthy process, thus impractical to face the immediate global challenge. Drug repurposing is an emerging strategy where existing medicines, having already been tested safe in humans, are redeployed to combat difficult-to-treat diseases. While using such repurposed drugs individually may ultimately not yield a significant clinical benefit, carefully combined cocktails could be very effective, as was for HIV in the 1990s; the urgent question now being which combination. Newlands Press Ltd 2020-03-25 2020-03 /pmc/articles/PMC7117595/ http://dx.doi.org/10.4155/fdd-2020-0010 Text en © 2020 Suranga L Senanayake This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Editorial
Senanayake, Suranga L
Drug repurposing strategies for COVID-19
title Drug repurposing strategies for COVID-19
title_full Drug repurposing strategies for COVID-19
title_fullStr Drug repurposing strategies for COVID-19
title_full_unstemmed Drug repurposing strategies for COVID-19
title_short Drug repurposing strategies for COVID-19
title_sort drug repurposing strategies for covid-19
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117595/
http://dx.doi.org/10.4155/fdd-2020-0010
work_keys_str_mv AT senanayakesurangal drugrepurposingstrategiesforcovid19